Form4.ai tracks every SEC insider trade in real time. See every VRTX insider filing with a free account — no card.
See every VRTX insider filing — free account, no card.
Free accountVERTEX PHARMACEUTICALS INC / MA (VRTX) has 6 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Oct. 22, 2026.
Open-market value, last 90 days
No open-market buys or sales in this period.
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 22, 2026 SEC filing | Brennan Daniel J. Director | Grant / award | $400,259 | — |
| Sep 10, 2026 SEC filing | van Grunsven Jasper EVP, CP and NPPO | Grant / award | — | — |
| Sep 1, 2026 SEC filing | Ambrose Kristen SVP & Chief Accounting Officer | Grant / award | — | — |
Create a free account to see all 6 VRTX filings from the last 90 days. No card needed.
Create free accountWant VRTX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.